Cargando…
The regulatory role of DPP4 in atherosclerotic disease
The increasing prevalence of atherosclerosis has become a worldwide health concern. Although significant progress has been made in the understanding of atherosclerosis pathogenesis, the underlying mechanisms are not fully understood. Recent studies suggest dipeptidyl peptidase-4 (DPP4), a regulator...
Autores principales: | Duan, Lihua, Rao, Xiaoquan, Xia, Chang, Rajagopalan, Sanjay, Zhong, Jixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472996/ https://www.ncbi.nlm.nih.gov/pubmed/28619058 http://dx.doi.org/10.1186/s12933-017-0558-y |
Ejemplares similares
-
Oxidized LDL upregulates macrophage DPP4 expression via TLR4/TRIF/CD36 pathways
por: Rao, Xiaoquan, et al.
Publicado: (2019) -
A Potential Role for Dendritic Cell/Macrophage-Expressing DPP4 in Obesity-Induced Visceral Inflammation
por: Zhong, Jixin, et al.
Publicado: (2013) -
Monocyte DPP4 Expression in Human Atherosclerosis Is Associated With Obesity and Dyslipidemia
por: Rao, Xiaoquan, et al.
Publicado: (2018) -
Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function
por: Gong, Quan, et al.
Publicado: (2015) -
Role of T Lymphocytes in Type 2 Diabetes and Diabetes-Associated Inflammation
por: Xia, Chang, et al.
Publicado: (2017)